Oklo Stock: Big Loss, Bigger Milestone — What Investors Need to Know

TLDR

• Oklo posted a Q1 net loss of $33.1 million ($0.19/share), wider than the $9.8 million loss a year ago, with zero revenue.
• The Nuclear Regulatory Commission approved the Principal Design Criteria for Oklo’s Aurora powerhouse last week.
• CEO Jacob DeWitte has confirmed commercial operations are targeted to begin by 2028 at the latest.
• Oklo ended Q1 with $1.59 billion in cash and $614.5 million in marketable debt securities, representing ~82% of total assets.
• H.C. Wainwright reiterated a Buy rating and $90 price target on the stock following the Q1 results.

Oklo stock ticked up 0.6% in premarket trading Wednesday after the nuclear start-up reported its first-quarter results and announced a key regulatory win — even as its losses grew.

Oklo Inc., OKLO

The company posted a Q1 net loss of $33.1 million, or $0.19 per share. That’s a steep jump from the $9.8 million loss, or $0.07 per share, recorded in the same quarter last year. Analysts had been forecasting a $0.20 per share loss, so the result came in just slightly ahead of expectations.

Oklo has no revenue. It’s still in the development stage, which makes traditional financial metrics hard to apply.

The company spent $32.8 million on infrastructure and equipment during the quarter — above the $29.8 million analysts expected. Operating expenses came in at $51.5 million, down about 10% from $57.1 million the prior quarter.

Oklo finished Q1 with $1.59 billion in cash and $614.5 million in marketable debt securities. Together, those figures represent roughly 82% of total assets.

The stock had closed 5.8% lower the previous session before the premarket bounce Wednesday.

NRC Approves Key Design Criteria for Aurora

The headline regulatory news: the Nuclear Regulatory Commission approved the Principal Design Criteria for Oklo’s Aurora powerhouse at Idaho National Laboratory last week.

Think of this as the foundational safety and performance rulebook for the plant. It’s a meaningful step in the approval process, though full commercial approval is still pending.

CEO Jacob DeWitte has consistently told Barron’s that commercial operations are on track to begin by 2028 at the latest.

Revenue Pathways Starting to Take Shape

While Aurora moves through the regulatory process, Oklo is working on other ways to bring in money.

Subsidiary Atomic Alchemy secured a license earlier this year to begin sales from its radiochemistry laboratory in Idaho. Oklo noted Tuesday that its first isotope customer was “pending.”

The company has also been building credibility through high-profile partnerships. Last month, Oklo tapped Nvidia’s AI infrastructure to advance nuclear fuel modeling and simulations with Los Alamos National Laboratory.

Meta Platforms is among Oklo’s existing customers, which has helped support the company’s profile with investors.

Since going public in May 2024, Oklo has traded heavily on promise. Its stock surged 238% in 2025 while the S&P 500 gained 16%. This year has been quieter — Oklo is up just 2.6% in 2026 versus the S&P 500’s 8.1% gain.

The company currently carries a market cap of $12.81 billion despite generating no revenue — a valuation that some analysts have flagged as stretched.

H.C. Wainwright kept its Buy rating and $90 price target on the stock following the Q1 results.

The post Oklo Stock: Big Loss, Bigger Milestone — What Investors Need to Know appeared first on CoinCentral.